DBS Bank analyst Nico Chen upgraded Novo Nordisk (NVO) to Hold from Sell with a DKK 340 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk freezes non-critical hiring, Reuters reports
- Viking Therapeutics drop may be partially ‘sell the news,’ says H.C. Wainwright
- Novo Nordisk Announces Executive Share Transactions Amid Market Confidence
- Eli Lilly, Novo Nordisk up 2% each after Viking obesity pill trial results
- Novo Nordisk price target lowered to $70 from $105 at TD Cowen